Back to Search
RICKY PATEL, DO
DO
Internal Medicine Physician
NPI: 1902256167IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2019-02865(NC)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
WILLIAM CAREY UNIVERSITY COLLEGE OF OSTEOPATHIC MEDICINE
Class of 2016
Research & Publications (20)
Circumferential pharyngeal reconstruction: history, critical analysis of techniques, and current therapeutic recommendations.
PMID 19565471·Head Neck·2010
6-review
Isolation and characterization of phenol degrading yeast.
PMID 18798176·J Basic Microbiol·2009
8-other
Morbidity and functional outcomes following gastro-omental free flap reconstruction of circumferential pharyngeal defects.
PMID 19260110·Head Neck·2009
8-other
Ah receptor represses acute-phase response gene expression without binding to its cognate response element.
PMID 19333233·Lab Invest·2009
7-preclinical
Acoustic and perceptual cues to contrastive stress in dysarthria.
PMID 18695019·J Speech Lang Hear Res·2009
8-other
Revision arthroscopic capsulolabral reconstruction for recurrent instability of the shoulder.
PMID 18978266·J Bone Joint Surg Br·2008
8-other
Polymeric black tea polyphenols inhibit mouse skin chemical carcinogenesis by decreasing cell proliferation.
PMID 18400024·Cell Prolif·2008
7-preclinical
RNA-mediated gene silencing of superoxide dismutase (bcsod1) in Botrytis cinerea.
PMID 19000009·Phytopathology·2008
8-other
Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway.
PMID 18037152·Toxicol Appl Pharmacol·2008
7-preclinical
Postselective two-photon interference from a continuous nonclassical stream of photons emitted by a quantum dot.
PMID 18518580·Phys Rev Lett·2008
8-other
Polymeric black tea polyphenols induce phase II enzymes via Nrf2 in mouse liver and lungs.
PMID 18358244·Free Radic Biol Med·2008
7-preclinical
ATLAS--a high-throughput affinity-based screening technology for soluble proteins: technology application using p38 MAP kinase.
PMID 18336086·Assay Drug Dev Technol·2008
8-other
Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
PMID 18313521·Int J Radiat Oncol Biol Phys·2008
4-observational
Effectiveness of selective neck dissection in the treatment of the clinically positive neck.
PMID 18642289·Head Neck·2008
4-observational
Characterization of symmetric and asymmetric lipid bilayers composed of varying concentrations of ganglioside GM1 and DPPC.
PMID 18298108·J Phys Chem B·2008
8-other
The pOT and pLOB vector systems: improving ease of transgene expression in Botrytis cinerea.
PMID 19164879·J Gen Appl Microbiol·2008
8-other
The prognostic impact of extent of bone invasion and extent of bone resection in oral carcinoma.
PMID 18300706·Laryngoscope·2008
8-other
Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
PMID 18021753·Brain Res·2008
8-other
Kinetic and equilibrium studies on the biosorption of reactive black 5 dye by Aspergillus foetidus.
PMID 17251011·Bioresour Technol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 W 27TH ST
LUMBERTON, NC 28358 - Phone
- (910) 735-8781
Quick Facts
- NPI
- 1902256167
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile